History of yellow fever 1,235 fatalities were recorded of an estimated 12,000 cases. Smaller outbreaks occurred in Saint-Nazaire in France, Swansea in Wales, and in other European port cities following the arrival of vessels carrying the mosquito vector. The first mention of the disease by the name "yellow fever" occurred in 1744. Many famous people, mostly during the 18th through the 20th centuries, contracted and then recovered from, or died of, yellow fever. The Yellow Fever Epidemic of 1793 struck during the summer in Philadelphia, Pennsylvania, where the highest fatalities in the United States were recorded. The disease probably was brought by refugees and
Yellow fever ribavirin is an effective early treatment of many pathological features of the disease. Ribavirin treatment during the first five days after virus infection improved survival rates, reduced tissue damage in the liver and spleen, prevented hepatocellular steatosis, and normalised levels of alanine aminotransferase, a liver damage marker. The mechanism of action of ribavirin in reducing liver pathology in yellow fever virus infection may be similar to its activity in treatment of hepatitis C, a related virus. Because ribavirin had failed to improve survival in a virulent rhesus model of yellow fever infection, it had been previously discounted as a possible